Evaluation of Liquid vs. Tablet Buprenorphine - 6
Phase 2
Completed
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 1
- Registration Number
- NCT00000341
- Locations
- ๐บ๐ธ
Friends Research Institute, Los Angeles, California, United States
Dextroamphetamine as an Adjunct in Cocaine Treatment - 1
Phase 2
Completed
- Conditions
- Cocaine-Related DisordersSubstance-Related Disorders
- Interventions
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 120
- Registration Number
- NCT00000304
- Locations
- ๐บ๐ธ
University of Texas Health Science Center, Houston, Texas, United States
Buprenorphine Dosing Interval - 5
Phase 2
Completed
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2005-08-17
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000209
- Locations
- ๐บ๐ธ
Friends Research Institute, Los Angeles, California, United States
Methamphetamine Abuse Treatment in Patients With AIDS - 1
Phase 4
Completed
- Conditions
- Substance-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000321
- Locations
- ๐บ๐ธ
Friends Research Institute, Los Angeles, California, United States
Buprenorphine Maintenance for Opiate Dependence - 6
Phase 2
Completed
- Conditions
- Opioid-Related DisordersSubstance-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000357
- Locations
- ๐บ๐ธ
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7
Phase 1
Completed
- Conditions
- Opioid-Related DisordersSubstance-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000358
- Locations
- ๐บ๐ธ
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Alterations in Serotonergic Functions in Cocaine Addicts - 1
Phase 1
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000312
- Locations
- ๐บ๐ธ
VA Medical Center, Brooklyn, New York, United States
Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1
Phase 1
Completed
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 120
- Registration Number
- NCT00000320
- Locations
- ๐บ๐ธ
Friends Research Institute, Los Angeles, California, United States
Dextroamphetamine-Cocaine Behavioral Intervention - 5
Phase 2
Completed
- Conditions
- Cocaine-Related Disorders
- Interventions
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 54
- Registration Number
- NCT00000308
- Locations
- ๐บ๐ธ
University of Texas Health Science Center, Houston, Texas, United States
Pergolide Treatment for Substance Abusers - 4
Phase 2
Completed
- Conditions
- Cocaine-Related DisordersSubstance-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000269
- Locations
- ๐บ๐ธ
New York State Psychiatric Institute, New York, New York, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath